In this issue:
ROSELLA: Relacorilant combo efficacious in platinum-resistant disease
Comparable oncological outcomes with paclitaxel- vs cisplatin-based HIPEC
Complete cytoreduction vital for optimal survival
Histologic transformation of low-grade serous cancer portends poor outcome
TME is an essential component of debulking surgery for advanced disease
Real-world ovarian cancer care and its survival impact on older adults
Palbociclib + letrozole has modest activity in recurrent hormone-positive disease
Elevated risk of relapse in low-stage ARID1A wild-type CCOC with TIL depletion
Oncologist perceptions of “cure” in advanced ovarian cancer
HALO: The prevalence of HRD in newly diagnosed ovarian cancer
Please login below to download this issue (PDF)